Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - HK
$ 6.13
0.822 %
$ 79.8 M
Market Cap
-19.16
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
--
EBIT
Estimate
--
Net Income
Estimate
--
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Regencell Bioscience Holdings Limited
RGC has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart RGC
RGC has no estimates for Revenue Forecast.
EBIT FORECAST
EBIT Forecast Chart RGC
RGC has no estimates for EBIT Forecast.
NET INCOME FORECAST
Net Income Chart RGC
RGC has no estimates for Net Income.